XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa
MacLaren RE. et al, (2025), Ophthalmology Science, 5, 100595 - 100595
A novel frameshift variant in LAMP2 gene mimicking choroideremia carrier retinopathy
Narayan A. et al, (2024), Ophthalmic Genetics, 1 - 8
Multimodal Evaluation and Management of Wagner Syndrome—Three Patients from an Affected Family
Szeligowski T. et al, (2024), Genes, 15, 1178 - 1178
Expanding the genotypic and phenotypic spectra with a novel variant in the ciliopathy gene, CFAP410, associated with selective cone degeneration.
Borchert GA. et al, (2024), Ophthalmic Genet, 1 - 7
Establishing Clinical Trial Endpoints in Selecting Patients for RPGR Retinal Gene Therapy.
Christou EE. et al, (2024), Transl Vis Sci Technol, 13
Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study
Lam BL. et al, (2024), Ophthalmology, 131, 1083 - 1093
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye.
Ng BW. et al, (2024), Prog Retin Eye Res, 102
Retinal Focal Nodular Gliosis (Vasoproliferative Tumors) Have Varied Clinical Courses Requiring Tailored Management: A Case Series.
Ie A. et al, (2024), Ocul Oncol Pathol, 10, 175 - 181
Robot-Assisted Eye Surgery: A Systematic Review of Effectiveness, Safety, and Practicality in Clinical Settings.
Thirunavukarasu AJ. et al, (2024), Transl Vis Sci Technol, 13
In Silico CRISPR-Cas-Mediated Base Editing Strategies for Early-Onset, Severe Cone-Rod Retinal Degeneration in Three Crumbs homolog 1 Patients, including the Novel Variant c.2833G>A.
Shamsnajafabadi H. et al, (2024), Genes (Basel), 15
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy.
Borchert GA. et al, (2024), Front Neurosci, 18
Is RPGR-related retinal dystrophy associated with systemic disease? A case series
Han RC. et al, (2023), Ophthalmic Genetics, 44, 577 - 584
Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center
Kiraly P. et al, (2023), Biomolecules, 13, 1484 - 1484
Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial
MacLaren RE. et al, (2023), Nature Medicine, 29, 2464 - 2472
Correlation Between Fundus Autofluorescence Pattern and Retinal Function on Microperimetry in Choroideremia.
Poli FE. et al, (2023), Transl Vis Sci Technol, 12
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
Borchert GA. et al, (2023), Cells, 12, 2092 - 2092
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy.
Shamsnajafabadi H. et al, (2023), Cells, 12
Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations
von Krusenstiern L. et al, (2023), JAMA Ophthalmology, 141, 275 - 275